Bioactive bone cements containing nano-sized titania particles for use as bone substitutes

Area of Science:

• Biomaterials Science
• Orthopedic Research
• Nanotechnology

Background:

• Polymethylmethacrylate (PMMA)-based bone cements are widely used in orthopedic surgery.
• Improving the osteoconductivity of PMMA bone cements is crucial for enhanced bone integration.
• Titania (TiO2) nanoparticles offer potential for bioactive bone cement development.

Purpose of the Study:

• To evaluate the mechanical properties and osteoconductivity of novel PMMA-based bone cements containing nano-sized titania (TiO2) particles.
• To compare the performance of silanized TiO2 incorporated cements against non-silanized TiO2 and conventional PMMA cement.
• To identify a promising bioactive bone cement for bone substitute applications.

Main Methods:

• Preparation of three PMMA-based bone cements: T50c (50 wt% TiO2), ST50c (50 wt% silanized TiO2), and ST60c (60 wt% silanized TiO2).
• In vivo evaluation in rat tibiae for 6 and 12 weeks.
• Assessment of osteoconductivity using scanning electron microscopy (SEM), contact microradiography (CMR), and Giemsa surface staining.

Main Results:

• SEM analysis showed direct bone apposition with ST60c and ST50c, but not with T50c or PMMAc.
• ST60c exhibited significantly superior osteoconduction compared to other cements at all time points.
• The compressive strength of ST60c was comparable to that of conventional PMMA cement (PMMAc).

Conclusions:

• Silanized titania nanoparticles significantly improve the osteoconductivity of PMMA-based bone cements.
• ST60c demonstrates excellent bone integration and mechanical properties, making it a promising candidate for bone substitute applications.
• The incorporation of silanized TiO2 represents a viable strategy for developing advanced bioactive bone cements.